The Patent Finder
US

Antibody Molecules to TIM-3 and Uses Thereof

US 9,605,070 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jan 30, 2035 · High confidence

Held by Novartis AG
Filed Jan 30, 2015 as application 14/610,837 · Granted Mar 28, 2017
Base term, 20 years from filing
Today
20 years from filing
2015 2035
Clock starts
Jan 30, 2015
Term ends
Jan 30, 2035
Granted
Mar 28, 2017
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 30, 2015, when this application, 14/610,837, was filedJan 30, 2035High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJan 30, 2035High confidence

This family

US 9,605,070this patent
Jan 2035
Jan 2035
US 10,472,419In force
Jan 2035
Jan 2035
US 9,884,913In force
Jan 2035
Jan 2035
US 11,155,620In force
Feb 2035
Feb 2035
US 10,981,990In force
Jan 2035
Jan 2035
Application 17/484,794Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 13, 2015
Reel 34957, frame 449
Hu, Tiancen; Taraszka, John A.; Xu, FangminNovartis Institutes for Biomedical Research Inc.Assignment of Assignor's Interest
Feb 13, 2015
Reel 34957, frame 485
Novartis Institutes for Biomedical Research Inc.Novartis AGAssignment of Assignor's Interest
Dec 5, 2016
Reel 40807, frame 566
Dana-Farber Cancer InstNational Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. GovernmentConfirmatory License
Mar 9, 2017
Reel 41517, frame 458
Sabatos-peyton, Catherine Anne; Mataraza, Jennifer Marie; Blattler, Walter A.; Hicklin, Daniel J.Costim Pharmaceuticals Inc.Assignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 547
Vasquez, MaximilianoGalaxy Biotech, LLCAssignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 562
Galaxy Biotech, LLCCostim Pharmaceuticals Inc.Assignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 575
Costim Pharmaceuticals Inc.Novartis AGAssignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 621
Harris, Alan S.Novartis Institutes for Biomedical Research, Inc.Assignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 639
Novartis Institutes for Biomedical Research, Inc.Novartis AGAssignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 670
Brannetti, Barbara; Huber, Thomas; Pietzonka, ThomasNovartis Pharma AGAssignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 681
Novartis Pharma AGNovartis AGAssignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 697
Freeman, Gordon JamesDana-Farber Cancer Institute, Inc.Assignment of Assignor's Interest
Mar 9, 2017
Reel 41517, frame 722
Dekruyff, Rosemarie H.; Umetsu, Dale T.Children's Medical Center CorporationAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited